Pune, Feb. 15, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Aortic Aneurysm Market is expected to clock US$ 11.29 billion by 2031 and to grow at a CAGR of 9.81% during the forecast period.
The global Aortic Aneurysm Market is witnessing significant growth, driven by the increasing prevalence of cardiovascular diseases, advancements in diagnostic imaging technologies, and rising demand for minimally invasive treatment options. With a focus on early detection, risk assessment, and innovative therapies, stakeholders in the healthcare industry are working to improve outcomes for individuals at risk of aortic aneurysms and related complications.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/aortic-aneurysm-market/8565
Aortic Aneurysm Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 4.85 billion |
| Revenue Forecast in 2031 | US$ 11.29 billion |
| CAGR | 9.81% |
| Base Year For Estimation | 2022 |
| Forecast Period | 2023-2031 |
| Historical Year | 2021 |
| Segments Covered | Type, Treatment, Product, End User, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Overview:
Aortic Aneurysm refers to the abnormal dilation of the aortic wall, which can occur in the thoracic (TAA) or abdominal (AAA) segments of the aorta. Left untreated, aortic aneurysms can lead to serious complications such as rupture, dissection, and life-threatening bleeding. The management of aortic aneurysms involves surveillance, risk factor modification, and timely intervention to prevent adverse events and improve patient outcomes.
Key Market Drivers:
- Increasing Disease Burden: Aortic Aneurysms represent a significant healthcare burden worldwide, particularly among aging populations and individuals with underlying cardiovascular risk factors such as hypertension, smoking, and atherosclerosis. The rising prevalence of these risk factors, coupled with improved diagnostic capabilities and screening programs, has led to a greater detection rate of asymptomatic aortic aneurysms, driving market growth.
- Advancements in Imaging Technology: Technological advancements in diagnostic imaging modalities, such as computed tomography angiography (CTA), magnetic resonance imaging (MRI), and ultrasound, have revolutionized the detection and characterization of aortic aneurysms. These imaging tools allow for accurate assessment of aneurysm size, morphology, and location, facilitating risk stratification, treatment planning, and surveillance of patients with aortic pathology.
- Shift Towards Minimally Invasive Interventions: There is a growing trend towards minimally invasive treatment approaches for aortic aneurysms, including endovascular repair with stent grafts and catheter-based techniques. Minimally invasive procedures offer several advantages over traditional open surgery, including reduced morbidity, shorter hospital stays, and faster recovery times, driving adoption among both patients and healthcare providers.
Competitive Landscape:
The Aortic Aneurysm Market features a competitive landscape with key players focusing on product innovation, clinical research, and strategic collaborations to expand their product portfolios and gain a competitive edge. Companies invest in developing novel stent graft designs, biocompatible materials, and advanced imaging technologies to enhance treatment outcomes and patient safety.
Challenges and Opportunities:
While the Aortic Aneurysm Market presents significant opportunities for growth and innovation, challenges such as device-related complications, long-term durability of endovascular implants, and access to specialized care in underserved regions need to be addressed. However, ongoing advancements in medical device technology, biomaterials, and patient-centered care offer opportunities to improve treatment algorithms and optimize outcomes for patients with aortic pathology.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL AORTIC ANEURYSM DEVICES MARKET - ANALYSIS & FORECAST, BY TYPE
- Thoracic Aortic Aneurysm (TAA)
- Abdominal Aortic Aneurysm (AAA)
- GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY TREATMENT
- Open Surgical Repair (OSR)
- Endovascular Aneurysm Repair (EVAR)
- GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY PRODUCTS
- Stent Grafts
- Catheters
- GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY END USER
- Hospitals
- Ambulatory Surgery Centers
- Clinic
Future Outlook:
The Aortic Aneurysm Market is poised for continued growth, driven by the increasing awareness of cardiovascular health, aging populations, and advancements in medical technology. As healthcare systems prioritize preventive strategies, early detection, and personalized treatment approaches, stakeholders can collaborate to reduce the morbidity and mortality associated with aortic aneurysms, ultimately improving patient outcomes and quality of life.
In conclusion, the Aortic Aneurysm Market represents a vital segment within the cardiovascular healthcare industry, addressing the complex needs of patients with aortic pathology. By leveraging innovation, collaboration, and evidence-based practice, stakeholders can drive progress in the prevention, diagnosis, and treatment of aortic aneurysms, ensuring optimal care for individuals at risk of this potentially life-threatening condition.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8565
Browse other reports:
The global Salmonella treatment market is expected to register a revenue CAGR of 7.3% during the forecast period from 2022 to 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global scoliosis management market was valued at US$ 2.2 billion in 2021 and is expected to register a revenue CAGR of 4.3% to reach US$ 3.21 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global sterilization indicator tape market was valued at US$ 121 million in 2021 and is expected to register a revenue CAGR of 3.8% to reach US$ 169.26 million by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global surgical drill market was valued at US$ 1.2 billion in 2021 and is expected to register a revenue CAGR of 6.1% to reach US$ 2.04 billion by 2030.
Based on the deep-dive market assessment study by Growth Plus Reports, the global Whole exome sequencing market was valued at US$ 1.02 billion in 2021 and is expected to register a revenue CAGR of 18.70% to reach US$ 4.80 billion by 2030.
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.
